Abstract

The present review addresses the history of intermittent claudication in terms of pathogenetic and therapeutic approach. The reduced blood supply to the affected limb was initially explained by ‘vasospasm theory’, and vasodilators were the first drugs to be used. However, the demonstration that they induce the blood steal phenomenon led to the demise of vasodilating therapy. The 1970s marked the shift in interest from ‘vessel’ to ‘blood’, and drugs that improve blood rheology were introduced. In the 1990s, research focused on the metabolic regulation of the ischaemic muscle, and the ‘metabolic therapy’ has emerged as a new approach with which to improve walking capacity in claudicant patients.

References

[1]

Bouley
JF
. Claudication intermittente des membres postérieurs délcrminée par l'oblitération des artècres fémorales.
Rec Med Vet
.
1831
;
8
:
517

[2]

Brodie
BC
. Lectures Illustratives of Various Subjects in Pathology and Surgery. London: A. Spottiswoode; 1846. (Cited by Lewis et al.[10])

[3]

Charcot
JMC
. Sur la claudication intermittente observe dans un cas d'oblitération complete de Tune des artéeres iliaques primitives.
CR Soc Biol (Paris)
.
1858
;
5
:
225
(Cited by Lindquist[7])

[4]

Erb
. Das intermittierende hinken and andere nervöse Störungen in folge I.
Von Gefässerkrankungen Z Nervenk
.
1898
;
13
:
1

[5]

Comroe
JH
. Paroxysmal angiospasm dolorosa.
Ann Clin Med
.
1922
;
1
:
313
–316

[6]

Leary
WV
, Allen EV. Intermittent claudication as a result of arterial spasm induced by walking.
Am Heart J
.
1941
;
22
:
719
–724

[7]

Lindquist
T
. Intermittent claudication and vascular spasm. I. Is vascular spasm a contributing cause of intermittent claudication in patients with structural disease of the arteries?
Acta Med Scand
.
1945
;
121
:
32
–44

[8]

Ejrup
B
. Tonoscillography after exercise.
Acta Med Scand Suppl
.
1948
;
211
:
1
–7

[9]

Thulesius
O
. Haemodynamic studies on experimental obstruction of the femoral artery in the cat.
Acta Physiol Scand Suppl
.
1962
;
199
:
1
–9

[10]

Lewis
T
, Pichering G, Rotschild P. Observations upon muscular pain in intermittent claudication.
Heart
.
1931
;
15
:
359
–366

[11]

De Bakey
ME
, Burch G, Thorpe R, Ochsner A. The borrowinglending haemodynamic phenomenon (hemometakinesia) and its therapeutic application in peripheral vascular disturbances.
Ann Surg
.
1947
;
126
:
880
–887

[12]

Wezler
K
. Die Function der Peripheren Strombahngebiete. Regensburg.
JB Ärztl Forbild
.
1954
;
II/X
:
462

[13]

Ashton
H
. Critical closing pressure in the human peripheral vascular beds.
Clin Sci
.
1962
;
22
:
79
–86

[14]

Skinner
JS
, Strandness DE. Exercise and intermittent claudication. 1. Effects of repetition, and intensity of exercise.
Circulation
.
1967
;
36
:
15
–22

[15]

Winsor
T
, Hyman C, Payne JH. Exercise and limb circulation in health and disease.
Arch Surg (Chicago)
.
1959
;
78
:
184
–190

[16]

Allwood
MJ
. Redistribution of blood flow limbs with obstruction of a main artery.
Clin Sci
.
1962
;
22
:
279
–288

[17]

Hansteen
V
, Lorentsen E. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
Acta Med Scand Suppl
.
1974
;
556
:
3
–62

[18]

Gillespie
JA
. An evaluation of vasodilation drugs in occlusive vascular disease by measurement.
Angiology
.
1966
;
17
:
280
–285

[19]

Coffman
JD
, Mannick JA. Failure of vasodilator drugs in arteriosclerosis obliterans.
Ann Intern Med
.
1972
;
76
:
35
–39

[20]

Chiariello
M
, Ribeiro LGT, Davis MA, et al. ‘Reverse coronary steal’ induced by coronary vasoconstriction following coronary occlusion in dogs.
Circulation
.
1977
;
56
:
809
–815

[21]

Brevetti
G
, Rengo F, Chiariello M, et al. Reduction of blood flow following ischemia in arteriopathic patients: reversion of the phenomenon induced by propranolol.
Angiology
.
1977
;
28
:
687
–694

[22]

Brevetti
G
, Chiariello M, Rengo F, et al. Protective effects of the propranolol on the exercise induced reduction of blood flow in arteriopathic patients.
Angiology
.
1979
;
30
:
696
–702

[23]

Brevetti
G
, Chiariello M, Ferulano GP, et al. Propranolol-induced riverse vascular steal in arteriopathic patients.
Angiology
.
1982
;
33
:
78
–89

[24]

Dormandy
JA
, Hoare E, Colley J, et al. Clinical, haemodynamic, theological, and biochemical findings in 126 patients with intermittent claudication.
BMJ
.
1973
;
4
:
576
–581

[25]

Dormandy
JA
, Hoare E, Khattab AH, et al. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication.
BMJ
.
1973
;
4
:
581
–583

[26]

Reid
HL
, Dormandy JA, Barnes AJ, et al. Impaired red cell deformability in peripheral vascular disease.
Lancet
.
1976
;
1
:
666
–668

[27]

Ciuffetti
G
, Mercari M, Bombardini M, et al. Leukocyte behaviour in controlled ischaemia of the calves.
J Clin Pathol
.
1989
;
42
:
1083
–1087

[28]

Neumann
FJ
, Wass W, Diehm C, et al. Activation and decreased deformability of neutrophils after intermittent claudication.
Circulation
.
1990
;
82
:
922
–929

[29]

Hess
H
, Franke I, Jauch M. Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases. [in German]
Fortschr Med
.
1973
;
91
:
743
–748

[30]

Heidrich
H
, Schlichting K, Ott M. Changes in blood viscosity due to pentoxifyline.
IRCS Med Sc
.
1976
;
4
:
368
–372

[31]

Brevetti
G
, Abate S, La vecchia G, et al. La pentossifillina net trattamento defle arteriopatia obliteranti al secondo stadio.
Progr Med
.
1979
;
35
:
363
–368

[32]

Ehrly
AM
. The effects of pentoxifyline on the deformability of erythrocytes and or the muscular oxygen pressure in patients with chronic arterial disease.
J Med
.
1979
;
10
:
331
–338

[33]

Schmalzer
EA
, Chien S. Filterability of subpopulation of leukocytes: effect of pentoxifyline.
Blood
.
1984
;
64
:
542
–546

[34]

Cameron
HA
, Waller PC, Ramsay LE. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of the published clinical trials 1965–1985.
Br J Clin Pharmacol
.
1988
;
26
:
569
–576

[35]

Radack
K
, Wyderski RJ. Conservative management of intermittent claudication.
Ann Intern Med
.
1997
;
113
:
135
–146

[36]

Hiatt
WR
, Nawaz D, Regensteiner JG, Hossack KF. The evaluation of exercise performance in patients with peripheral vascular disease.
J Cardiopulm Rehab
.
1988
;
12
:
525
–532

[37]

Hiatt
WR
, Wolfel EE, Regensteiner JG, Brass EP. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease.
J Appl Physiol
.
1992
;
73
:
346
–353

[38]

Regensteiner
JC
, Wolfel EE, Brass EP, et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease.
Circulation
.
1993
;
87
:
413
–421

[39]

Lundgren
F
, Dahllof AG, Schersten T, Bylund-Fellenius AC. Muscle enzyme adaptation, effect of different treatments and consequences on walking performance.
Clin Sci
.
1988
;
77
:
485
–493

[40]

Kemp
GJ
, Hands LJ, Ramaswani G, et al. Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy.
Clin Sci
.
1995
;
89
:
581
–590

[41]

Pipinos
II
, Shepard AD, Anagnostopoulos PV, Katsamouris A, Boska MD. Phosphoros 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicatiog skeletal muscle.
J Vasc Surg
.
2000
;
31
:
944
–952

[42]

Cerretelli
P
, Marconi C. L-carnitine supplementation in humans the effects on physical performance.
Int J Sports Med
.
1990
;
11
:
1
–14

[43]

Hiatt
WR
, Regensteiner JG, Wolfe] EE, Ruff L, Brass EE. Carnitine and acylcarnitine metabolism during exercise in humans: dependence on skeletal muscle metabolic state.
J Clin Invest
.
1989
;
84
:
1167
–1173

[44]

Hiatt
WR
, Nawaz D, Brass EP. Carnitine metabolism during exercise in patients with peripheral vascular disease.
J Appl Physiol
.
1987
;
62
:
2383
–2387

[45]

Brevetti
G
, Angelini C, Rosa M, et al. Muscle carnitine deficiency in patients with severe peripheral vascular disease.
Circulation
.
1991
;
84
:
1490
–1495

[46]

Brevetti
G
, Di Lisa F, Perna S, et al. Carnitine related alterations in patients with intermittent claudication. Indication for carnitine therapy.
Circulation
.
1996
;
93
:
1685
–1689

[47]

Brevetti
G
, Chiariello M, Ferulano G, et al. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double blind, cross-over study.
Circulation
.
1988
;
77
:
767
–773

[48]

Brevetti
G
, Fania M, De Amicis T, et al. Changes in skeletal muscle histology and metabolism in patients undergoing exercise deconditioning: effect of propionyl-L-carnitine.
Muscle Nerve
.
1997
;
20
:
1515
–1519

[49]

Tassani
V
, Cattapan F, Magnanimi L, Peschechera A. Anaplerotic effect of propionyl-carnitine in rat heart mitochondrial.
Biochem Biophys Res Commun
.
1994
;
199
:
949
–953

[50]

Brevetti
G
, Perna S, Sabbà C, et al. Superiority of L-propionyl carnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous doubleblind, cross-over study.
Eur Heart J
.
1992
;
133
:
251
–255

[51]

Brevetti
G
, Perna S, Sabbà C, et al. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo, controlled, dose titration, Multicenter study.
J Am Coll Cardiol
.
1995
;
26
:
1411
–1416

[52]

Brevetti
G
, Perna S, Sabbà C, et al. Effect of propionyl-L-carnitine on quality of life in intermittent claudication.
Am J Cardiol
.
1997
;
79
:
777
–780

[53]

Brevetti
G
, Diehm C, Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudication.
J Am Coll Cardiol
.
1999
;
34
:
1618
–1624

[54]

Foley
WT
. Treatment of gangrene of the feet and legs by walking.
Circulation
.
1957
;
15
:
689
–692

[55]

Gardner
AW
, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.
JAMA
.
1996
;
274
:
975
–980

[56]

Hiatt
WR
, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease.
Circulation
.
1990
;
81
:
602
–609

[57]

Hickey
NC
, Gosling P, Baar S, Shearman CP, Simms MH. Effect of exercise on the systemic inflammatory response to intermittent claudication.
Br J Surg
.
1990
;
77
:
1121
–1124

[58]

Hickman
P
, Harrison DK, Hill A, et al. Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage.
Adv Exp Med Biol
.
1994
;
361
:
565
–570

[59]

Khaira
HS
, Nash GB, Bahra PS, et al. Thromboxane and neutrophil changes following intermittent claudication suggest ischaemia-reperfusion injury.
Eur J Vasc Endovasc Surg
.
1995
;
10
:
31
–35

[60]

Kirk
G
, Hickman P, McLaren M, et al. Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease.
Eur J Vasc Endovasc Surg
.
1999
;
18
:
434
–438

[61]

Mangiafico
RA
, Malatino LS, Spada RS, et al. Treadmill exerciseinduced release of endothelin-1 patients with peripheral arterial occlusive disease at Fontaine stage IIb.
Int Angiol
.
2000
;
19
:
14
–17

[62]

Bode-Boger
SM
, Boger RH, Alfke H, et al. L-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study.
Circulation
.
1996
;
93
:
85
–90

[63]

Boger
RH
, Bode-Boger SM, Thiele W, et al. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial disease.
J Am Coll Cardiol
.
1999
;
32
:
1336
–1344

[64]

Hickey
NC
, Shearman CP, Gosling P, Simms MA. Assessment of intermittent claudication by quantitation of exercise-induced microalbuminuria.
Eur J Vasc Surg
.
1990
;
4
:
601
–606

[65]

Iwata
H
, Matsushita M, Nishikimi N, Sakwai T, Nimura Y. Intestinal permeability is increased in patients with intermittent claudication.
J Vasc Surg
.
2000
;
31
:
1003
–1007

This content is only available as a PDF.